Maze Therapeutics MAZE
NASDAQ MAZE
$26.64 -0.01 (-0.06%)
As of: Oct 2, 2026 · 12:51 PM EDT

Maze Therapeutics (MAZE) Long-Term Investments (2025 - 2026)

Updated

Maze Therapeutics (MAZE) posted Long-Term Investments of $83.82 million for Q2 2026, up 694.1% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Long-Term Investments (2025 - 2026) Analysis & Trends

At the end of FY2025, Maze Therapeutics' Long-Term Investments came in at $18.11 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Maze Therapeutics 1.51 Bn 1.51 Bn - 83.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 83.82 Mn
Mar 31, 2026 10.56 Mn
Dec 31, 2025 18.11 Mn
API Access

Maze Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=MAZE&period=max&api_key=YOUR_API_KEY